EUVIMEDEUVIMED entdecken
Open Access

Economic Burden of Tuberculosis in Iran: A Nationwide Analysis by Drug Resistance and Cost Components

Masoud Arefnezhad iD, Mahshid Nasehi iD, Aliakbar Fazaeli iD, Saeed Sharafi iD, Rajabali Daroudi iD

Journal of Research in Health Sciences · 2025

DOI: 10.34172/jrhs.11215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Research in Health Sciences, 2025. Verfasst von Masoud Arefnezhad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management, Policy and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cost of Illness, Tuberculosis, Multidrug-Resistant, Health Care Costs, Tuberculosis. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuberculosis (TB) remains a significant global health crisis, regaining its status as the leading cause of death in 2023. Quantifying its economic burden is essential for crafting effective public health strategies. This study aimed to estimate the economic burden of TB in Iran. Study Design: This study employed a cross-sectional design.

Methods

A prevalence-based approach was used to estimate the economic burden of TB in Iran, accounting for cost variations across TB types and cost categories. Costs were categorized as direct medical, direct non-medical, and indirect, and were calculated for suspected TB patients as well as for those with drug-sensitive TB, multidrug-resistant TB, and extensively drug-resistant TB. Data were extracted from various sources, including the National Tuberculosis Registration System, national TB diagnosis and treatment guidelines in Iran, official medical service tariffs, and previous studies.

Results

Of 210,544 individuals screened, 7,221 were diagnosed with TB, of whom 81.0% had pulmonary TB and 19.0% had extrapulmonary TB. Drug-sensitive TB accounted for 99.4% of cases, multidrug-resistant TB 0.6%, and extensively drug-resistant TB 0.0%. Diagnostic costs represented 48.0% of the total economic burden (approximately Int’l$4.71 million), while post-diagnosis costs totaled Int’l$5.15 million. Overall, economic burden, including all diagnostic and treatment expenses, amounted to approximately Int’l$9.86 million.

Conclusion

This study underscores the significant economic burden of TB in Iran, encompassing both pre-diagnosis and post-diagnosis expenses, with direct medical costs representing the largest component. Effective healthcare strategies and comprehensive public health approaches are crucial to reducing these costs and improving patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost of IllnessTuberculosis, Multidrug-ResistantHealth Care CostsTuberculosisHumansIranCross-Sectional StudiesMaleFemaleAdultMiddle AgedYoung AdultAdolescentPrevalenceAntitubercular AgentsAgedChildChild, Preschool

Stichwörter der Autor:innen

Cost of illnessExtensively drug-resistantIranMultidrug-resistantTuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Health Management, Policy and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
  • National TB and Leprosy Control Department, Ministry of Health and Medical Education, Tehran, Iran.

ORCID-Profile: Masoud Arefnezhad, Mahshid Nasehi, Aliakbar Fazaeli, Saeed Sharafi, Rajabali Daroudi

Zitieren

APA

Arefnezhad, M., Nasehi, M., Fazaeli, A., Sharafi, S., & Daroudi, R. (2025). Economic Burden of Tuberculosis in Iran: A Nationwide Analysis by Drug Resistance and Cost Components. Journal of Research in Health Sciences. https://doi.org/10.34172/jrhs.11215

Vancouver

Arefnezhad M, Nasehi M, Fazaeli A, Sharafi S, Daroudi R. Economic Burden of Tuberculosis in Iran: A Nationwide Analysis by Drug Resistance and Cost Components. Journal of Research in Health Sciences. 2025. doi:10.34172/jrhs.11215

BibTeX
@article{Arefnezhad2025,
  author = {Arefnezhad, Masoud and Nasehi, Mahshid and Fazaeli, Aliakbar and Sharafi, Saeed and Daroudi, Rajabali},
  title = {Economic Burden of Tuberculosis in Iran: A Nationwide Analysis by Drug Resistance and Cost Components},
  journal = {Journal of Research in Health Sciences},
  year = {2025},
  doi = {10.34172/jrhs.11215}
}
Kostenlos starten →